Triptolide enhances chemotherapeutic efficacy of antitumor drugs in non-small-cell lung cancer cells by inhibiting Nrf2-ARE activity. [electronic resource]
Producer: 20190322Description: 1-9 p. digitalISSN:- 1096-0333
- A549 Cells
- Animals
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Agents, Alkylating -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Antioxidant Response Elements -- drug effects
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Diterpenes -- administration & dosage
- Dose-Response Relationship, Drug
- Drug Resistance, Neoplasm -- drug effects
- Epoxy Compounds -- administration & dosage
- Hep G2 Cells
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Mice
- Mice, Inbred C57BL
- NF-E2-Related Factor 2 -- antagonists & inhibitors
- Phenanthrenes -- administration & dosage
- Treatment Outcome
- Tumor Burden -- drug effects
- Xenograft Model Antitumor Assays -- methods
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.